Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy - npj Breast Cancer npj Breast Cancer - Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy

Analysis of the phase 3 #KEYNOTE119 trial showed immune activity (high TILs, T-cell signals, or high mutation burden) may be predictive of response to pembrolizumab in pts with met #TNBC. #breastcancer #NPJbreastcancer
nature.com/articles/s41...